cancer therapy

The Background, Advantages of, and Considerations for Radiolabeled Peptides

Blog / By

Integrin αvβ3 and RGD Binding The use of radiolabeled peptides is a well-established tool in researching and treating many diseases and conditions. Selective receptor-targeting peptides are utilized as agents due to their rapid circulatory and tissue clearance and the high affinity and specificity to their targets. Peptides also have a relatively small size and low […]

The Background, Advantages of, and Considerations for Radiolabeled Peptides Read More »

Ferring Pharmaceuticals and SK pharmteco enter into commercial gene therapy manufacturing deal

News / By

Biopharmaceutical contract manufacturer SK pharmteco commits to production, testing, and release of Ferring’s U.S. approved Adstiladrin® (nadofaragene firadenovec-vncg) The deal assures diversity of supply to meet future long-term plans for expanded availability of the gene therapy Two additional state-of-the-art manufacturing facilities for Adstiladrin® are near completion in Finland and the U.S. Saint-Prex, Switzerland and King

Ferring Pharmaceuticals and SK pharmteco enter into commercial gene therapy manufacturing deal Read More »

Links
Compliance
Twitter Linkedin-in Facebook-square
Copyright ©2024 by SK pharmteco Inc. All Rights Reserved
Scroll to Top

Enter your details to access Marketing Materials

"*" indicates required fields